Key result
Oral ribavirin and intravenous immune globulin infusions led to clinical improvement in a 63-year-old man with RSV-mediated pericarditis following autologous hematopoietic stem cell transplant.
Case Report (n=1)
This case report highlights respiratory syncytial virus as a potential cause of pericarditis in immunocompromised patients, which can be successfully treated with ribavirin and intravenous immune globulin.
Answers are grounded in this paper and cite their sources.
RSV pericarditis merits consideration post-transplant; this Level 5 case leaves open ribavirin-IVIG efficacy.
We describe a case of pericarditis and large pericardial effusion in a 63-year-old African-American man undergoing autologous hematopoietic stem cell transplant for multiple myeloma. Pericardial tissue biopsy demonstrated fibrinous pericarditis, and immunohistochemistry stains were positive for respiratory syncytial virus. The patient improved with oral ribavirin and intravenous immune globulin infusions.
No takes yet. Share an insight, caveat, or question.
Rubach et al. (2013) conducted a case report in Pericarditis and large pericardial effusion mediated by respiratory syncytial virus (n=1). Oral ribavirin and intravenous immune globulin infusions was evaluated on Clinical improvement. Oral ribavirin and intravenous immune globulin infusions led to clinical improvement in a 63-year-old man with RSV-mediated pericarditis following autologous hematopoietic stem cell transplant.
Synapse has enriched 10 related papers. Consider them for comparative context: